PSNC Briefing 011/21: Serious Shortage Protocols (SSPs) updated endorsing guidance
Published on: 28th May 2021 | Updated on: 9th June 2022
From 1 June 2021, the Department of Health and Social Care (DHSC) has approved the use of a new endorsement to claim for any supplies made in accordance with an SSP. The new endorsement uses the code ‘SSP’ followed by the three-digit reference number applicable to the SSP for example, SSP007 for Fluoxetine 30mg capsules would be endorsed as ‘SSP 007’.
Details of the new SSP endorsement and transitional arrangements are outlined in June 2021 Drug Tariff (Part II Clause 9E). These changes are also reflected in PSNC’s updated SSP endorsing guidance (see link below)
If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.
To browse other PSNC briefings on dispensing and supply click here.
For more information on this topic please email firstname.lastname@example.org